Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Clive R Taylor

1PUBLICATIONS

23CO-AUTHORS

Predictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jun 26, 2025

FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.

Federico Rojo, Clive R Taylor, Carlos Barrios

Pageof 1

Frequent Collaborators

1 joint publications

Federico Rojo

1 joint publications

Carlos Barrios

1 joint publications

Laura Torrecillas

1 joint publications

Manuel Ruiz-Borrego

1 joint publications

Sandra Perez-Buira

1 joint publications

Jose Bines

1 joint publications

Angel Guerrero-Zotano

1 joint publications

Jose A Garcia-Saenz

1 joint publications

Roberto Torres

1 joint publications

Juan de la Haba-Rodriguez

Frequent Collaborators

1 joint publications

Federico Rojo

1 joint publications

Carlos Barrios

1 joint publications

Laura Torrecillas

1 joint publications

Manuel Ruiz-Borrego

Top Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

See more related videos

Top Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

See more related videos